company background image
2395 logo

Shin Nippon Biomedical Laboratories TSE:2395 Stock Report

Last Price

JP¥1.68k

Market Cap

JP¥69.8b

7D

9.4%

1Y

-2.7%

Updated

26 Dec, 2024

Data

Company Financials +

Shin Nippon Biomedical Laboratories, Ltd.

TSE:2395 Stock Report

Market Cap: JP¥69.8b

My Notes

Capture your thoughts, links and company narrative

Shin Nippon Biomedical Laboratories, Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shin Nippon Biomedical Laboratories
Historical stock prices
Current Share PriceJP¥1,681.00
52 Week HighJP¥1,996.00
52 Week LowJP¥970.00
Beta-0.067
1 Month Change8.17%
3 Month Change39.27%
1 Year Change-2.66%
3 Year Change18.38%
5 Year Change166.40%
Change since IPO-23.24%

Recent News & Updates

Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00

Dec 19
Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00

Shin Nippon Biomedical Laboratories (TSE:2395) Is Paying Out A Dividend Of ¥30.00

Dec 02
Shin Nippon Biomedical Laboratories (TSE:2395) Is Paying Out A Dividend Of ¥30.00

Recent updates

Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00

Dec 19
Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00

Shin Nippon Biomedical Laboratories (TSE:2395) Is Paying Out A Dividend Of ¥30.00

Dec 02
Shin Nippon Biomedical Laboratories (TSE:2395) Is Paying Out A Dividend Of ¥30.00

What Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) 25% Share Price Gain Is Not Telling You

Nov 25
What Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) 25% Share Price Gain Is Not Telling You

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Sep 19
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Earnings Miss: Shin Nippon Biomedical Laboratories, Ltd. Missed EPS By 88% And Analysts Are Revising Their Forecasts

Aug 09
Earnings Miss: Shin Nippon Biomedical Laboratories, Ltd. Missed EPS By 88% And Analysts Are Revising Their Forecasts

Little Excitement Around Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) Earnings As Shares Take 28% Pounding

Aug 06
Little Excitement Around Shin Nippon Biomedical Laboratories, Ltd.'s (TSE:2395) Earnings As Shares Take 28% Pounding

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Jul 26
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Jul 12
Shin Nippon Biomedical Laboratories' (TSE:2395) Dividend Will Be ¥20.00

Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 21
Shin Nippon Biomedical Laboratories' (TSE:2395) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 10
Shin Nippon Biomedical Laboratories, Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Mar 12
Shin Nippon Biomedical Laboratories (TSE:2395) Is Due To Pay A Dividend Of ¥30.00

Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

Feb 27
Shin Nippon Biomedical Laboratories (TSE:2395) Has Affirmed Its Dividend Of ¥30.00

Shareholder Returns

2395JP Life SciencesJP Market
7D9.4%0.6%0.5%
1Y-2.7%-11.1%13.6%

Return vs Industry: 2395 exceeded the JP Life Sciences industry which returned -11.1% over the past year.

Return vs Market: 2395 underperformed the JP Market which returned 13.6% over the past year.

Price Volatility

Is 2395's price volatile compared to industry and market?
2395 volatility
2395 Average Weekly Movement5.6%
Life Sciences Industry Average Movement5.6%
Market Average Movement3.6%
10% most volatile stocks in JP Market7.3%
10% least volatile stocks in JP Market1.9%

Stable Share Price: 2395's share price has been volatile over the past 3 months compared to the JP market.

Volatility Over Time: 2395's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.

About the Company

FoundedEmployeesCEOWebsite
19571,451Ryoichi Nagatawww.snbl.co.jp

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally. It offers non-clinical studies, including single/repeated dose toxicity studies, antigenicity studies, skin sensitization studies, genotoxicity studies, carcinogenicity studies, local irritation studies, inhalation toxicity studies, TK studies, characteristic studies, stability studies, dependence studies, reproductive and developmental toxicity studies, safety pharmacological studies, and pharmacokinetic studies. The company also engages in the investigator brochure preparation support, clinical trial protocol creation support, clinical trial medical institution, investigational drug allocation, clinical trial request/contract, monitoring, quality management, data management, statistical analysis work, comprehensive report creation support, electronic application support, regulatory affairs consulting, and creating informed consent documents support services.

Shin Nippon Biomedical Laboratories, Ltd. Fundamentals Summary

How do Shin Nippon Biomedical Laboratories's earnings and revenue compare to its market cap?
2395 fundamental statistics
Market capJP¥69.82b
Earnings (TTM)JP¥3.90b
Revenue (TTM)JP¥27.07b

18.0x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2395 income statement (TTM)
RevenueJP¥27.07b
Cost of RevenueJP¥12.62b
Gross ProfitJP¥14.45b
Other ExpensesJP¥10.56b
EarningsJP¥3.90b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 05, 2025

Earnings per share (EPS)93.58
Gross Margin53.38%
Net Profit Margin14.39%
Debt/Equity Ratio95.9%

How did 2395 perform over the long term?

See historical performance and comparison

Dividends

3.0%

Current Dividend Yield

53%

Payout Ratio

Does 2395 pay a reliable dividends?

See 2395 dividend history and benchmarks
When do you need to buy 2395 by to receive an upcoming dividend?
Shin Nippon Biomedical Laboratories dividend dates
Ex Dividend DateMar 28 2025
Dividend Pay DateJun 25 2025
Days until Ex dividend92 days
Days until Dividend pay date181 days

Does 2395 pay a reliable dividends?

See 2395 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 07:49
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shin Nippon Biomedical Laboratories, Ltd. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuki TsukamotoBofA Global Research
Akitada IwasaDaiwa Securities Co. Ltd.
Masao YoshidaIchiyoshi Research Institute Inc.